Latest Insider Transactions at Jeld Wen Holding, Inc. (JELD)
This section provides a real-time view of insider transactions for Jeld Wen Holding, Inc. (JELD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of JELD-WEN Holding, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of JELD-WEN Holding, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2022
|
Daniel J Castillo EVP & President, North America |
SELL
Payment of exercise price or tax liability
|
Direct |
4,582
-2.86%
|
$105,386
$23.77 P/Share
|
|
Dec 13
2021
|
Roderick Wendt Director |
SELL
Open market or private sale
|
Indirect |
106,400
-3.01%
|
$2,660,000
$25.29 P/Share
|
|
Dec 13
2021
|
Roderick Wendt Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
141,669
+1.97%
|
$2,408,373
$17.12 P/Share
|
|
Nov 05
2021
|
Roderick Wendt Director |
SELL
Open market or private sale
|
Indirect |
17,350
-0.51%
|
$468,450
$27.25 P/Share
|
|
Nov 01
2021
|
John R Linker EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,495
-8.68%
|
$337,365
$27.37 P/Share
|
|
Nov 01
2021
|
Steven E Wynne Director |
SELL
Open market or private sale
|
Direct |
13,596
-13.24%
|
$367,092
$27.1 P/Share
|
|
Nov 01
2021
|
Steven E Wynne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,596
+19.83%
|
$285,516
$21.77 P/Share
|
|
Aug 18
2021
|
Onex Corp |
SELL
Open market or private sale
|
Direct |
14,883,094
-100.0%
|
$416,726,632
$28.5 P/Share
|
|
Aug 11
2021
|
Roderick Wendt Director |
SELL
Open market or private sale
|
Indirect |
5,000
-0.15%
|
$145,000
$29.0 P/Share
|
|
Aug 10
2021
|
Roderick Wendt Director |
SELL
Open market or private sale
|
Indirect |
10,000
-0.29%
|
$280,000
$28.29 P/Share
|
|
Aug 09
2021
|
Peter Farmakis EVP & President, Australasia |
SELL
Open market or private sale
|
Direct |
38,481
-11.78%
|
$1,038,987
$27.85 P/Share
|
|
Aug 09
2021
|
Peter Farmakis EVP & President, Australasia |
BUY
Exercise of conversion of derivative security
|
Direct |
13,431
+2.56%
|
$255,189
$19.88 P/Share
|
|
Aug 06
2021
|
Peter Farmakis EVP & President, Australasia |
SELL
Open market or private sale
|
Direct |
84,380
-11.94%
|
$2,362,640
$28.07 P/Share
|
|
Aug 06
2021
|
Peter Farmakis EVP & President, Australasia |
BUY
Exercise of conversion of derivative security
|
Direct |
79,380
+7.63%
|
$793,800
$10.39 P/Share
|
|
Jun 18
2021
|
Gary S Michel Chair, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,346
-5.79%
|
$383,650
$25.46 P/Share
|
|
Jun 08
2021
|
Roderick Wendt Director |
SELL
Open market or private sale
|
Indirect |
10,000
-3.4%
|
$280,000
$28.06 P/Share
|
|
Jun 01
2021
|
Peter Farmakis EVP & President, Australasia |
SELL
Open market or private sale
|
Direct |
5,336
-3.15%
|
$149,408
$28.51 P/Share
|
|
May 13
2021
|
Onex Corp |
SELL
Open market or private sale
|
Direct |
10,000,000
-40.19%
|
$280,000,000
$28.8 P/Share
|
|
May 07
2021
|
Bruce M. Taten Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,404
-5.45%
|
$102,120
$30.88 P/Share
|
|
May 07
2021
|
Martha L Byorum Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,140
-8.22%
|
$64,200
$30.88 P/Share
|
|
May 03
2021
|
Daniel J Castillo EVP & President, North America |
SELL
Open market or private sale
|
Direct |
1,333
-0.83%
|
$39,990
$30.23 P/Share
|
|
Apr 29
2021
|
William F Banholzer Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,333
+14.46%
|
-
|
|
Apr 29
2021
|
G Nord David Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,333
+50.0%
|
-
|
|
Apr 29
2021
|
Cynthia Marshall Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,333
+50.0%
|
-
|
|
Apr 29
2021
|
Greg G Maxwell Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,333
+14.1%
|
-
|
|
Apr 29
2021
|
Bruce M. Taten Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,333
+6.48%
|
-
|
|
Apr 29
2021
|
Tracey Joubert Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,333
+50.0%
|
-
|
|
Apr 29
2021
|
Steven E Wynne Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,333
+9.48%
|
-
|
|
Apr 29
2021
|
Suzanne Stefany Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,333
+15.29%
|
-
|
|
Mar 23
2021
|
Daniel J Castillo EVP & President, North America |
SELL
Payment of exercise price or tax liability
|
Direct |
17,165
-9.61%
|
$446,290
$26.09 P/Share
|
|
Mar 03
2021
|
Onex Corp |
SELL
Open market or private sale
|
Direct |
8,000,000
-24.33%
|
$224,000,000
$28.61 P/Share
|
|
Mar 01
2021
|
Roderick Wendt Director |
SELL
Open market or private sale
|
Indirect |
10,000
-3.28%
|
$300,000
$30.76 P/Share
|
|
Feb 26
2021
|
Timothy Craven EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
1,207
-3.45%
|
$35,003
$29.65 P/Share
|
|
Feb 26
2021
|
Daniel J Castillo EVP & President, North America |
SELL
Payment of exercise price or tax liability
|
Direct |
1,374
-0.76%
|
$39,846
$29.65 P/Share
|
|
Feb 26
2021
|
Scott Vining SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,003
-4.7%
|
$29,087
$29.65 P/Share
|
|
Feb 26
2021
|
John R Linker EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,182
-0.81%
|
$34,278
$29.65 P/Share
|
|
Feb 23
2021
|
Gary S Michel Chair, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
72,889
+21.58%
|
-
|
|
Feb 23
2021
|
Roya Behnia EVP, CLO and Corporate Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
10,920
+7.37%
|
-
|
|
Feb 23
2021
|
Timothy Craven EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
8,807
+20.11%
|
-
|
|
Feb 23
2021
|
Peter Farmakis EVP & President, Australasia |
BUY
Grant, award, or other acquisition
|
Direct |
8,861
+4.98%
|
-
|
|
Feb 23
2021
|
Daniel J Castillo EVP & President, North America |
BUY
Grant, award, or other acquisition
|
Direct |
11,833
+6.17%
|
-
|
|
Feb 23
2021
|
David R Guernsey EVP |
BUY
Grant, award, or other acquisition
|
Direct |
10,033
+30.45%
|
-
|
|
Feb 23
2021
|
Scott Vining SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,819
+29.26%
|
-
|
|
Feb 23
2021
|
John R Linker EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
13,125
+8.29%
|
-
|
|
Feb 22
2021
|
Roderick Wendt Director |
SELL
Open market or private sale
|
Indirect |
10,000
-3.18%
|
$280,000
$28.35 P/Share
|
|
Feb 19
2021
|
Steven E Wynne Director |
SELL
Open market or private sale
|
Direct |
31,766
-46.17%
|
$857,682
$27.25 P/Share
|
|
Feb 19
2021
|
Steven E Wynne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
31,766
+31.59%
|
$381,192
$12.47 P/Share
|
|
Feb 01
2021
|
Daniel J Castillo EVP & President, North America |
SELL
Payment of exercise price or tax liability
|
Direct |
4,632
-2.68%
|
$125,064
$27.11 P/Share
|
|
Nov 06
2020
|
Roderick Wendt Director |
SELL
Open market or private sale
|
Indirect |
10,000
-3.08%
|
$220,000
$22.64 P/Share
|
|
Nov 05
2020
|
Roderick Wendt Director |
SELL
Open market or private sale
|
Indirect |
10,150
-3.03%
|
$243,600
$24.96 P/Share
|